Press Releases
Leading Comprehensive Cancer Center in France, Centre Léon Bérard, Joins the TriNetX Network to Improve Access to Innovative Therapies for Its Patients
Lyon, France, September 9, 2022 - Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised of healthcare organizations and life sciences companies driving...
TriNetX Develops New Analytics Course with The University of Texas Medical Branch
Course Focuses on Integrating the Use of TriNetX with Biomedical Informatics Curriculum Cambridge, MA, August 10, 2022 — TriNetX, LLC partnered with The University of Texas Medical Branch (“UTMB”) on a new research and analytics course titled: Biomedical Informatics:...
Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX
Cambridge, MA, July 29, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the inaugural members of the Pediatric Collaboratory Network (PCN), comprised of...
Finnish Biobanks (FINBB) Partners with TriNetX to Increase Clinical and Biomedical Trials in Finland
Cambridge, MA, June 14, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Finnish Biobanks (FINBB), a cooperative owned by the six largest hospital...
TriNetX Launches Prospective Patient Monitoring Platform Leveraging Global Real-World Data
TriNetX Follow the Patient enables the generation of real-world evidence for prospective monitoring studies Cambridge, MA, May 13, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new...
Anshul Thakral Appointed to the TriNetX Board of Directors
Cambridge, MA, May 5, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the appointment of Anshul Thakral to the company’s board of directors. Mr. Thakral...